EUVIMEDEUVIMED entdecken
Open Access

Matrix-bound nanovesicles alleviate particulate-induced periprosthetic osteolysis

Runzhi Liao iD, Marley J Dewey iD, Jiayang Rong iD, Scott A Johnson iD, William A D'Angelo iD, George S Hussey iD, Stephen F Badylak iD

Science Advances · 2024

DOI: 10.1126/sciadv.adn1852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Runzhi Liao und 6 weiteren Autor:innen. Beteiligte Einrichtung: McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA. Hauptthemen laut MEDLINE: Osteolysis, Osteoclasts, RANK Ligand. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aseptic loosening of orthopedic implants is an inflammatory disease characterized by immune cell activation, chronic inflammation, and destruction of periprosthetic bone, and is one of the leading reasons for prosthetic failure, affecting 12% of total joint arthroplasty patients. Matrix-bound nanovesicles (MBVs) are a subclass of extracellular vesicle recently shown to mitigate inflammation in preclinical models of rheumatoid arthritis and influenza-mediated “cytokine storm.” The molecular mechanism of these anti-inflammatory properties is only partially understood. The objective of the present study was to investigate the effects of MBV on RANKL-induced osteoclast formation in vitro and particulate-induced osteolysis in vivo. Results showed that MBV attenuated osteoclast differentiation and activity by suppressing the NF-κB signaling pathway and downstream NFATc1, DC-STAMP, c-Src, and cathepsin K expression. In vivo, local administration of MBV attenuated ultrahigh molecular weight polyethylene particle-induced osteolysis, bone reconstruction, and periosteal inflammation. The results suggest that MBV may be a therapeutic option for preventing periprosthetic loosening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteolysisOsteoclastsRANK LigandAnimalsMiceExtracellular VesiclesCell DifferentiationNF-kappa BSignal TransductionOsteogenesisNanoparticlesExtracellular MatrixProsthesis FailureRAW 264.7 CellsDisease Models, Animal

Substanzen

RANK LigandNF-kappa B

Autor:innen und Institutionen

  • McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.
  • Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.
  • Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.
  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA.

ORCID-Profile: Runzhi Liao, Marley J Dewey, Jiayang Rong, Scott A Johnson, William A D'Angelo, George S Hussey, Stephen F Badylak

Förderung

  • NCATS NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Liao, R., Dewey, M. J., Rong, J., Johnson, S. A., D'Angelo, W. A., Hussey, G. S., & Badylak, S. F. (2024). Matrix-bound nanovesicles alleviate particulate-induced periprosthetic osteolysis. Science Advances. https://doi.org/10.1126/sciadv.adn1852

Vancouver

Liao R, Dewey MJ, Rong J, Johnson SA, D'Angelo WA, Hussey GS, et al. Matrix-bound nanovesicles alleviate particulate-induced periprosthetic osteolysis. Science Advances. 2024. doi:10.1126/sciadv.adn1852

BibTeX
@article{Liao2024,
  author = {Liao, Runzhi and Dewey, Marley J and Rong, Jiayang and Johnson, Scott A and D'Angelo, William A and Hussey, George S and Badylak, Stephen F},
  title = {Matrix-bound nanovesicles alleviate particulate-induced periprosthetic osteolysis},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adn1852}
}
Kostenlos starten →